Fear Potentiation and Fear Inhibition in Posttraumatic Stress Disorder
1 other identifier
interventional
425
1 country
1
Brief Summary
The current study will investigate the ability of people with and without fear symptoms after trauma to inhibit fear in an experimental situation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2001
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2001
CompletedFirst Submitted
Initial submission to the registry
September 14, 2005
CompletedFirst Posted
Study publicly available on registry
September 21, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 22, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
February 22, 2012
CompletedAugust 7, 2019
August 1, 2019
11.1 years
September 14, 2005
August 5, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fear potentiation of acoustic startle
Percent change in acoustic startle magnitude during visual cue conditioned to aversive stimuli, compared to trials without aversive stimuli
Baseline
Study Arms (3)
1
EXPERIMENTALSubjects with posttraumatic stress disorder
2
ACTIVE COMPARATORHealthy controls
3
ACTIVE COMPARATORCombat controls
Interventions
Eligibility Criteria
You may qualify if:
- Age 18-80
- Diagnosis of PTSD
- Healthy controls (no history of PTSD)
- Combat controls (no history of PTSD)
You may not qualify if:
- No drug or alcohol abuse or dependence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
Study Sites (1)
Atlanta VA Medical Center
Decatur, Georgia, 30033, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erica Duncan, MD
Emory University/Atlanta VA Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 14, 2005
First Posted
September 21, 2005
Study Start
January 1, 2001
Primary Completion
February 22, 2012
Study Completion
February 22, 2012
Last Updated
August 7, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share